Literature DB >> 15570173

Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain.

Heather A Bimonte-Nelson1, Matthew E Nelson, Ann-Charlotte E Granholm.   

Abstract

Neurotrophin alterations have been associated with normal aging and age-related neurodegenerative disease, as well as cognitive status. Estrogen influences expression of mRNA and protein of neurotrophins and their receptors, and affects cognitive performance in young ovariectomized (Ovx) rats. The current investigation evaluated whether estrogen or estrogen plus progesterone affects neurotrophin protein levels in cognitive brain regions in the aged Ovx rat. While estrogen treatment increased BDNF, NGF, and NT3 levels in entorhinal cortex, progesterone abated the effects of estrogen resulting in neurotrophin levels comparable to aged Ovx rats not given hormone. Our findings suggest that the aged female brain is responsive to estrogen in cognitive brain regions, and that progesterone can reverse these estrogen effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570173     DOI: 10.1097/00001756-200412030-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  48 in total

1.  Long-term replacement of estrogen in combination with medroxyprogesterone acetate improves acquisition of an alternation task in middle-aged female rats.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Behav Neurosci       Date:  2011-12-05       Impact factor: 1.912

Review 2.  Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol.

Authors:  Alesia V Prakapenka; Heather A Bimonte-Nelson; Rachael W Sirianni
Journal:  Ann Biomed Eng       Date:  2017-06-20       Impact factor: 3.934

3.  Contrasting effects of individual versus combined estrogen and progestogen regimens as working memory load increases in middle-aged ovariectomized rats: one plus one does not equal two.

Authors:  Alesia V Prakapenka; Ryoko Hiroi; Alicia M Quihuis; Catie Carson; Shruti Patel; Claire Berns-Leone; Carly Fox; Rachael W Sirianni; Heather A Bimonte-Nelson
Journal:  Neurobiol Aging       Date:  2017-12-07       Impact factor: 4.673

4.  Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation.

Authors:  Lu Fan; Zaorui Zhao; Patrick T Orr; Cassie H Chambers; Michael C Lewis; Karyn M Frick
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

5.  Pubertal ovarian hormone exposure reduces the number of myelinated axons in the splenium of the rat corpus callosum.

Authors:  M A Yates; J M Juraska
Journal:  Exp Neurol       Date:  2007-10-25       Impact factor: 5.330

Review 6.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

7.  Estradiol and Progesterone have Opposing Roles in the Regulation of Fear Extinction in Female Rats.

Authors:  Bronwyn M Graham; Melissa Daher
Journal:  Neuropsychopharmacology       Date:  2015-07-09       Impact factor: 7.853

8.  Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats.

Authors:  Jenna C Carroll; Emily R Rosario; Christian J Pike
Journal:  Neurosci Lett       Date:  2008-09-07       Impact factor: 3.046

9.  Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices.

Authors:  Claudia C Aguirre; Michel Baudry
Journal:  Eur J Neurosci       Date:  2009-01-17       Impact factor: 3.386

10.  Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat.

Authors:  Ann-Charlotte Granholm; Heather A Bimonte-Nelson; Alfred B Moore; Matthew E Nelson; Linnea R Freeman; Kumar Sambamurti
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.